PTSD clinical trials
Showing 201–250 of 362 active trials. Describe your situation to see which ones you may be eligible for.
- REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Improving Therapeutic Learning for PTSD
- FLOAT for Healthcare PTSS
- Advancing Skills Through Consultation, Education, and Novel Technologies
- The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD
- Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974
- Early General Anesthesia to Limit Experiences of Trauma During Cesarean Section-Pilot Study
- Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease
- Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat
- An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
- Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series
- Evaluation of the H.O.O.V.E.S. Healing Intensives Program
- VISN 19 MIRECC Research Database
- Long-Term Outcomes Following HBOT
- NYSCF Scientific Discovery Biobank
- RIVER At Home Ketamine Protocols
- An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- AIMS Medical Outcomes Study
- Retinal Imaging in Neurodegenerative Disease
- Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
- Temporal Interference in Psychiatry (TIP): Neuromodulation Using Temporal Interference
- A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation
- SMART Therapist Training: A Hybrid Factorial-SMART Design
- Inflammatory Challenge and Fear
- Neural Connectivity During Therapy for Adolescent PTSD
- Computational Assessment of GABA Receptor Modulation in PTSD
- Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.
- Non-invasive Nerve Stimulation for PTSD and Sleep
- Targeting the Default Mode Network: A TMS-fMRI Study
- The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
- eTMS for Veterans and First Responders With PTSD
- Biomarkers in the Retina for Prognosticating Mental Health Treatments
- LIFU Mechanisms for PTSD in Healthcare Workers
- Advancing Couple and Family Alcohol Treatment Through Patient-Oriented Research and Mentorship
- The Influence of Aerobic Exercise on Consolidation of Fear Extinction Learning in PTSD
- Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation
- Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
- TMS-fNIRS Personalized Dosing
- COPEWeb Training for Providers
- Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol: Effect on Psychophysiological Reactivity During Traumatic Imagery
- Impact of Dog Adoption and Training in Veterans With Post-traumatic Stress Symptoms and/or Other Mental Health Conditions
- Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
- Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
- Shared Decision Making in PTSD Treatment
- Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
- Fear and Avoidance in PTSD Patients
- Cognitive Control Training for Extinction in PTSD
- Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
- Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.